Purpura fulminans as the presenting manifestation in a patient with juvenile SLE

Turkish Journal of Pediatrics

Volumn 51, Issue 4, 2009, Pages 378-380

  Demirkaya, Erkan ^a   Çakmakli, Hasan Fatih ^a   Güçer, Şafak ^a   Aktay Ayaz, Nuray ^a   Gürgey, Aytemiz ^a   Özen, Seza ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Antiphospholipid syndrome; Plasmapheresis; Purpura fulminans; Systemic lupus erythematosus

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ACETYLSALICYLIC ACID; ANTINUCLEAR ANTIBODY; AZATHIOPRINE; BLOOD CLOTTING FACTOR 5 LEIDEN; C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CYCLOPHOSPHAMIDE; DOUBLE STRANDED DNA ANTIBODY; ENOXAPARIN; FRESH FROZEN PLASMA; HEPARIN; LUPUS ANTICOAGULANT; METHYLPREDNISOLONE; PHOSPHOLIPID ANTIBODY; PREDNISOLONE;

ANEMIA; ANTIBODY TITER; ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; AORTA VALVE DISEASE; ARTICLE; CASE REPORT; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; DISEASE ASSOCIATION; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG DOSE INCREASE; ERYTHEMA; ERYTHROCYTE SEDIMENTATION RATE; FATIGUE; FEMALE; FULMINATING PURPURA; HAIR LOSS; HEMATURIA; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; LENGTH OF STAY; LEUKOPENIA; PARTIAL THROMBOPLASTIN TIME; PERICARDIAL EFFUSION; PLASMAPHERESIS; PROTEINURIA; PROTHROMBIN TIME; PYURIA; SCHOOL CHILD; SKIN BIOPSY; SWELLING; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; TRANSTHORACIC ECHOCARDIOGRAPHY;

ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; CHILD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; PURPURA FULMINANS;

EID: 70649091204     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Avcin T, Silverman ED. Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome. Lupus 2007; 16: 627-633.
2. Olowu WA. Klebsiella-induced purpura fulminans in a Nigerian child: case report and a review of literature. West Afr J Med 2002; 21: 252-255.
3. Cervera R, Piette JC, Font J, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002; 46: 1019-1027. (Pubitemid 34303815)
4. Denburg SD, Carbotte RM, Denburg JA. Psychological aspects of systemic lupus erythematosus: cognitive function, mood, and self-report. J Rheumatol 1997; 24: 998-1003. (Pubitemid 27223645)
5. Wekking EM. Psychiatric symptoms in systemic lupus erythematosus: an update. Psychosom Med 1993; 55: 219-228. (Pubitemid 23093013)
6. Demirkaya E, Bilginer Y, Aktay-Ayaz N, et al. Neuropsychiatric involvement in juvenile systemic lupus erythematosus patients. Turk J Pediatr 2008; 50: 126-131.
7. Hanly JG, Walsh NM, Sangalang V. Brain pathology in systemic lupus erythematosus. J Rheumatol 1992; 19: 732-741.
8. Jennekens FG, Kater L. The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation. Rheumatology (Oxford) 2002; 41: 619-630.
9. Neuwelt CM, Lacks S, Kaye BR, Ellman JB, Borenstein DG. Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus. Am J Med 1995; 98: 32-41.
10. Donders RC, Kappelle LJ, Derksen RH, et al. Transient monocular blindness and antiphospholipid antibodies in systemic lupus erythematosus. Neurology 1998; 51: 535-540. (Pubitemid 28406334)
11. Mizuno R, Fujimoto S, Fujimoto T, et al. Catastrophic antiphospholipid antibody syndrome in systemic lupus erythematosus: an autopsy case report of a young woman. Intern Med 2000; 39: 763-764.
12. Male C, Foulon D, Hoogendoorn H, et al Predictive value of persistent versus transient antiphospholipid antibody subtypes for the risk of thrombotic events in pediatric patients with systemic lupus erythematosus. Blood 2005; 106: 4152-4158. (Pubitemid 41775921)
13. Becton DL, Stine KC. Transient lupus anticoagulants associated with hemorrhage rather than thrombosis: the hemorrhagic lupus anticoagulant syndrome. J Pediatr 1997; 130: 998-1000.
14. Asherson RA. The catastrophic antiphospholipid syndrome. J Rheumatol 1992; 19: 508-512.